| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT04523857 ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in… |
Enrollment reduced: 66 -> 44 participants |
| 2026-05-15 | NCT03598595 Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or… |
date change Primary completion pushed: 2026-05-31 -> 2027-05-31 |
| 2026-05-15 | NCT03598595 Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or… |
date change Completion pushed: 2026-05-31 -> 2027-05-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT05799378 | Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease | Systemic Lupus Erythematosus | Recruiting |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | Pneumonia | Recruiting |
| Phase 2 | |||
| NCT05041907 | Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early… | COVID-19 | Recruiting |
| NCT04841148 | Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast… | Breast Cancer | Recruiting |
| NCT04523857 | ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in… | Breast Cancer | Recruiting |
| NCT07443436 | Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant… | Interstitial Lung Disease | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05842174 | Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma | Hepatocellular Carcinoma | Recruiting |
| NCT04911816 | Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable… | Adenocarcinoma of the Pancreas | Recruiting |
| NCT04464759 | A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and… | Melanoma | Recruiting |
| NCT04201457 | A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG… | Low Grade Glioma (LGG) of Brain With BRAF Aberration | Active, Not Recruiting |
| NCT03598595 | Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or… | Recurrent Osteosarcoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT01480154 | Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT06408298 | HCQ in Resectable Localized Prostate Cancer | Resectable Localized Prostate Cancer | Recruiting |
| NCT04532346 | Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes | Interstitial Lung Disease | Recruiting |
| Not specified | |||
| NCT07343635 | The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by… | Erythematotelangiectatic Rosacea | Recruiting |